Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-27

Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, tolerability, and preliminary effectiveness of a single intradiscal dose of rhGDF-5 for early lumbar disc dege…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rhGDF-5 (recombinant human growth differentiation factor-5)

Snippet

Sponsor: DePuy Spine | Conditions: Early Lumbar Disc Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-27